In development. Not open, not taking money.

Everyone sells the on-ramp.
We're the landing.

Maintenance on a GLP-1 runs $299 to $449 a month. Between a quarter and two-fifths of what you lost is lean mass — and nobody is measuring it.

Holding, cycling, or planning to stop: the drug got cheap and easy, and the risk moved downstream. To tissue you can't see leaving, to intake nobody checks, and to regain that starts when you stop. We're building the measured exit.

25–40%
of the weight lost on a GLP-1 is lean mass — muscle and organ tissue — not fat.
AJMC, 2026 review
43%
of users hit the 1.2 g/kg protein intake used as the threshold for protecting it.
Frontiers in Nutrition, 2025 · n=69, small sample
1 in 2
stop within 12 months. Of those, 27% switch drugs and 20% restart the same one.
Cleveland Clinic, 2026 · n=7,938
$3,600+
a year already spent on the drug at a maintenance dose — up to $5,400.
LillyDirect / NovoCare, verified 2026-08-09
What this is

You already bought the weight loss.
This is about protecting the purchase.

Every company with distribution in this category earns when you stay on the drug. That isn't a conspiracy, it's an incentive — and it means the exit is the one part nobody is paid to get right. The clinics that started you have nowhere to send you. The manufacturers sell refills.

So we're building the other end: measure what's actually leaving, set protein and training targets against your own numbers instead of a population average, step the dose down on a schedule a licensed prescriber runs, and keep measuring — on the drug or off it.

01
You find us
Usually while searching for how to come off without losing what you gained.
02
Baseline
A marker panel at a draw site near you, plus a body-composition baseline. Around fifteen minutes.
03
Your numbers
Protein, training and repletion targets set to your results rather than an average. This part is ours.
04
The taper
A written protocol a licensed prescriber adopts, executes and can override at any point.
05
Keep measuring
Quarterly labs — including if you go back on. About one in five restart, and that's information, not failure.

Steps 02 through 05 describe the service as designed. None of it is operating yet — see the bottom of this page for exactly where we are.

Where we draw the line

What's proven, what's plausible,
and what's being sold to you anyway.

Most of this category sells plausible as proven. We'd rather show you the grading and lose the sale — including where it grades our own idea down.

GLP-1s produce substantial weight loss.
Proven
A meaningful share of that loss is lean mass.
Proven
Adequate protein plus resistance training preserves lean mass in a calorie deficit. Well established generally; not well studied specifically in people tapering off a GLP-1.
Proven
A structured, measured taper reduces regain. This is our own central claim, and it is not proven. We checked the entire white-label prescriber category and found no published GLP-1 de-prescribing standard anywhere. We're writing one and saying plainly that it's unproven.
Plausible
“Microdosing” a GLP-1 indefinitely for maintenance. A marketing term, not a clinical one. There is no established maintenance dose.
Marketing
Compounded peptide “maintenance blends.” Unproven as a category for this use, and the subject of active litigation.
Marketing
Planned pricing

$299 a month buys the drug.
We think the landing is worth $149.

These are the numbers we intend to charge when we open. Nothing is for sale today and there's no card field anywhere on this site.

To start · one time
$249
A baseline marker panel, a body-composition baseline, and a written titration and maintenance plan built on your results.
Membership · monthly
$149 / month
Quarterly monitoring labs, prescriber access for titration, and the interpretation layer kept current as your numbers move.
The drug is not included and would never be marked up. It's prescribed by a licensed clinician and ships from the manufacturer's own direct channel at their price. We intend to hold the first fifty members at $99/month for their first year — that's an intention, not a contract, and we'll put it in writing before anyone pays anything.
Talk to us

Fifteen minutes with the founder.

Not a sales script and not a nurse line — the person building this. We'll go through where you actually are, what your numbers are likely doing, and whether this will be worth your money when it exists. If it won't be, we'll say so.

Nothing is scheduled automatically. You tell us roughly when suits, we email you to agree a time. No card, no deposit, nothing to cancel.

Prefer not to talk to anyone? Switch to the second option and we'll send you the plan instead — it's genuinely useful even if you never buy anything.

A person reads every one of these by hand, so give us a day or two. We don't sell or share your information — see the privacy notice.